ABO-incompatible kidney transplantation using regenerative selective immunoglobulin adsorption

Journal of Clinical Apheresis

Volumn 27, Issue 2, 2012, Pages 51-60

  Teschner, Sven ^a,b   Stippel, Dirk ^a   Grunenberg, Roland ^a   Beck, Bodo ^a,b   Wahba, Roger ^a   Gathof, Birgit ^a   Benzing, Thomas ^a,b   Burst, Volker ^a,b  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

ABO incompatible; Glycosorb ; plasma exchange; regenerative immunoadsorption; single use immunoadsorption; TheraSorb

Indexed keywords

AGGLUTININ; BASILIXIMAB; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYCLONAL ANTIBODY; PREDNISOLONE; TACROLIMUS;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CLINICAL ARTICLE; DESENSITIZATION; FEMALE; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE;

ABO BLOOD-GROUP SYSTEM; ADSORPTION; ADULT; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; IMMUNOSORBENT TECHNIQUES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLASMA EXCHANGE;

EID: 84859712111     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21201     Document Type: Article

References (35)

1. Montgomery RA, Locke JE, King KE, Segev DL, Warren DS, Kraus ES, Cooper M, Simpkins CE, Singer AL, Stewart ZA, Melancon JK, Ratner L, Zachary AA, Haas M,. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009; 87: 1246-1255.
2. Stegall MD, Dean PG, Gloor JM,. ABO-incompatible kidney transplantation. Transplantation 2004; 78: 635-640.
3. Takahashi K, Saito K, Takahara S, Okuyama A, Tanabe K, Toma H, Uchida K, Hasegawa A, Yoshimura N, Kamiryo Y, Committee JA-IKT,. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-1096.
4. Tydén G, Kumlien G, Fehrman I,. Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab. Transplantation 2003; 76: 730-731.
5. Wilpert J, Fischer K-G, Pisarski P, Wiech T, Daskalakis M, Ziegler A, Neumann-Haefelin E, Drognitz O, Emmerich F, Walz G, Geyer M,. Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis. Nephrol Dial Transplant 2010; 25: 3778-3786.
6. Cardella CJ, Pei Y, Brady HR,. ABO blood group incompatible kidney transplantation: a case report and review of the literature. Clin Nephrol 1987; 28: 295-299.
7. Ota K, Takahashi K, Agishi T, Sonda T, Oka T, Ueda S, Amemiya H, Shiramizu T, Okazaki H, Akiyama N, Hasegawa A, Kawamura T, Takagi H, Ueno A,. Multicentre trial of ABO-incompatible kidney transplantation. Japanese Biosynsorb ABO-incompatible kidney transplant study group. Transpl Int 1992; 5 (Suppl 1): S40-S43.
8. Ichimaru N, Takahara S,. Japan's experience with living-donor kidney transplantation across ABO barriers. Nat Clin Pract Nephrol 2008; 4: 682-692.
9. Kumlien G, Ullstrom L, Losvall A, Persson LG, Tyden G,. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46: 1568-1575.
10. Oettl T, Zuliani E, Gaspert A, Hopfer H, Dickenmann M, Fehr T,. Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection. Transplantation 2010; 89: 702-706.
11. Matic G, Hofmann D, Winkler R, Tiess M, Michelsen A, Schneidewind JM, Hebestreit G, Keysser M, Müller W, Kinze EM, Ramlow W,. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption. Artif Organs 2000; 24: 103-107.
12. Braun N, Bosch T,. Immunoadsorption, current status and future developments. Expert Opin Investig Drugs 2000; 9: 2017-2038.
13. Laczika K, Knapp S, Derfler K, Soleiman A, Hörl WH, Druml W,. Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis 2000; 36: 392-395.
14. Haas M, Böhmig GA, Leko-Mohr Z, Exner M, Regele H, Derfler K, Hörl WH, Druml W,. Peri-operative immunoadsorption in sensitized renal transplant recipients. Nephrol Dial Transplant 2002; 17: 1503-1508.
15. Böhmig GA, Wahrmann M, Regele H, Exner M, Robl B, Derfler K, Soliman T, Bauer P, Müllner M, Druml W,. Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial. Am J Transplant 2007; 7: 117-121.
16. Böhmig GA, Regele H, Exner M, Derhartunian V, Kletzmayr J, Säemann MD, Hörl WH, Druml W, Watschinger B,. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 2001; 12: 2482-2489.
17. Matic G, Michelsen A, Hofmann D, Winkler R, Tiess M, Schneidewind JM, Müller W, Ramlow W,. Three cases of C-ANCA-positive vasculitis treated with immunoadsorption: possible benefit in early treatment. Ther Apher 2001; 5: 68-72.
18. Tydén G, Donauer J, Wadström J, Kumlien G, Wilpert J, Nilsson T, Genberg H, Pisarski P, Tufveson G,. Implementation of a Protocol for ABO-incompatible kidney transplantation-a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153-1155.
19. Wilpert, Geyer, Pisarski, Drognitz, Schulz-Huotari, Gropp, Goebel, Gerke, Teschner, Walz, Donauer,. On-demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2007; 22: 3048-3051.
20. Kumlien G, Wilpert J, Säfwenberg J, Tydén G,. Comparing the tube and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007; 84 (Suppl 12): S17-S19.
21. Dols LF, Kok NF, Terkivatan T, Tran KT, Alwayn IP, Weimar W, Ijzermans JN,. Optimizing left-sided live kidney donation: hand-assisted retroperitoneoscopic as alternative to standard laparoscopic donor nephrectomy. Transpl Int 23: 358-363.
22. Dols LF, Kok NF, Terkivatan T, Tran TC, d'Ancona FC, Langenhuijsen JF, zur Borg IR, Alwayn IP, Hendriks MP, Dooper IM, Weimar W, Ijzermans JN,. Hand-assisted retroperitoneoscopic versus standard laparoscopic donor nephrectomy: HARP-trial. BMC Surg 2010; 10: 11.
23. Kaplan AA,. A simple and accurate method for prescribing plasma exchange. ASAIO Trans 1990; 36: M597-M599.
24. Wilpert J, Geyer M, Teschner S, Schaefer T, Pisarski P, Schulz-Huotari C, Gropp A, Wisniewski U, Goebel H, Gerke P, Walz G, Donauer J,. ABO-incompatible kidney transplantation-proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers. J Clin Apher 2007; 22: 314-322.
25. Richter WO, Jacob BG, Ritter MM, Suhler K, Vierneisel K, Schwandt P,. Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies. Metabolism 1993; 42: 888-894.
26. Gordon BR, Sloan BJ, Parker TS, Saal SD, Levine DM, Rubin AL,. Humoral immune response following extracorporeal immunoadsorption therapy of patients with hypercholesterolemia. Transfusion 1990; 30: 327-332.
27. Geyer M, Fischer K-G, Drognitz, Walz G, Pisarski, Wilpert J,. ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab-insights and uncertainties. Contrib Nephrol 2009; 162: 47-60.
28. Rydberg L, Bengtsson A, Samuelsson O, Nilsson K, Breimer ME,. In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose. Transpl Int 2005; 17: 666-672.
29. Barnett N, Nightingale A, Maggs T, Needs M, Williams E, Curran D, Mamode N,. High anti-A titres may not preclude ABO-incompatible renal transplantation: an autoantibody could be the culprit. Nephrol Dial Transplant 2010; 25: 3794-3796.
30. Genberg H, Kumlien G, Wennberg L, Tyden G,. The efficacy of antigen-specific immunoadsorption and rebound of anti-A/B antibodies in ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2011; 26: 2394-2400.
31. Caro-Oleas JL, Gonzalez-Escribano MF, Gonzalez-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MA, Nunez-Roldan A,. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Nephrol Dial Transplant 2011 [Epub ahead of print; doi: 10.1093/ndt/gfr429].
32. Chin C, Chen G, Sequeria F, Berry G, Siehr S, Bernstein D, Rosenthal D, Reinhartz O, Tyan D,. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011; 30: 158-163.
33. Teschner S, Kurschat C, Burst V,. Therapeutic apheresis in transplantation: overview and critical evaluation of available modalities in respect to indications, evidence and costs. Transplantationsmedizin 2010; 22: 266-272.
34. Oettl T, Halter J, Bachmann A, Guerke L, Infanti L, Oertli D, Mihatsch M, Gratwohl A, Steiger J, Dickenmann M,. ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serialprotocol biopsies. Nephrol Dial Transplant 2009; 24: 298-303.
35. Strobel E WJ, Peters J,. Demonstration of isoagglutinins in intravenously applicable immunoglobulin preparations. Beitr Infusionsther Transfusionsmed 1994; 32: 200-202 (Article in German).